In another study involving APP/PS1 mice, CUMS was introduced under the same conditions, and in this instance, it not only promoted the expression of Aβ40 and Aβ42, but also induced neuronal injury and cognitive impairment [128]. This evidence concerns the gene APP and Cognitive impairment.